Nigeria: State to End Malaria Mortality By 2020 - Minister

[Premium Times] The Minister of Health, Isaac Adewole, said on Tuesday in Abuja that Nigeria would end malaria mortality by 2020.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Source Type: news

Related Links:

Condition:   Malaria Interventions:   Other: long lasting insecticidal nets with alpha-cypermethrin + pyriproxyfen (PPF LLIN, Royal Guard));   Other: long lasting insecticidal nets with deltamethrin + piperonyl butoxide (PBO LLIN, PermaNet 3.0));   Behavioral: Social behaviour change communication Sponsors:   University of California, San Francisco;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Chloroquine (CQ) and hydroxychloroquine (HCQ) are used in the treatment of malaria and various connective tissue diseases (CTD). They have been associated with muscle toxicity, mostly described as a proximal myopathy with evidence of lysosomal dysfunction on muscle biopsy. As patients with CTD may have muscle weakness due to myositis or steroid myopathy, the diagnosis can be missed or delayed. In this retrospective study, we aimed to define the clinical phenotype, laboratory features and treatment outcomes of CQ/HCQ-myopathy.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
The management of acute undifferentiated febrile illness (AFI) and the identification of patients who would benefit from antibacterial treatment is challenging, particularly in low-resource settings where diagnostic laboratory service is often lacking (Althaus et al., 2020). Hence, clinicians have to decide on empirical antibiotic prescription that is rarely based on definitive diagnosis and with clinical findings that often provide insufficient information. Even when laboratory capacity is available in these settings, it is mostly focused on malaria diagnosis (Bhargava et al., 2018; D ’Acremont et al., 2014), still ...
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Mosquito control remains a central pillar of efforts to reduce malaria burden in sub-Saharan Africa. However, insecticide resistance is entrenched in malaria vector populations, and countries with a high malaria burden face a daunting challenge to sustain malaria control with a limited set of surveillance and intervention tools. Here we report on the second phase of a project to build an open resource of high-quality data on genome variation among natural populations of the major African malaria vector species Anopheles gambiae and Anopheles coluzzii. We analyzed whole genomes of 1142 individual mosquitoes sampled from the...
Source: Genome Research - Category: Genetics & Stem Cells Authors: Tags: RESOURCES Source Type: research
Publication date: 26 September 2020Source: New Scientist, Volume 247, Issue 3301Author(s): Michael Le Page
Source: New Scientist - Category: Science Source Type: research
Publication date: Available online 25 September 2020Source: Trends in GeneticsAuthor(s): Thomas Hollin, Mohit Gupta, Todd Lenz, Karine G. Le Roch
Source: Trends in Genetics - Category: Genetics & Stem Cells Source Type: research
ahamse Globally, cancer has been identified as one of the leading causes of death in public health. Its etiology is based on consistent exposure to carcinogenic. Plant-derived anticancer compounds are known to be less toxic to the normal cells and are classified into acetylenic compounds, phenolics, terpenes, and phytosterols. Dicoma anomala is a perennial herb belonging to the family Asteraceae and is widely distributed in Sub-Saharan Africa and used in the treatment of cancer, malaria, fever, diabetes, ulcers, cold, and cough. This review aimed at highlighting the benefits of D. anomala in various therapeutic applica...
Source: Molecules - Category: Chemistry Authors: Tags: Review Source Type: research
Since the genesis of living organisms, the selection pressure or survival competition of any species has emerged through continuous, uncountable mutations. Prior to the emergence of Homo sapiens from subhuman primates, many pathogens, such as malaria species, have long and severely affected them(1). Beginning 100,000 to 40,000 years ago, modern humans migrated from Africa and adapted their cultures and phenotypes to extremes of altitudes, temperature, and humidity throughout the planet.
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Tags: Brief biography Source Type: research
Abstract Many children and adolescents around the world suffer from neurocognitive deficits due to chronic disorders, such as Human Immunodeficiency Virus (HIV) and malaria. Resource-limited settings exacerbate the risk of negative cognitive outcomes due to high prevalence of associated disorders, poverty, and limited access to interventions. Current literature does not provide consensus regarding the efficacy of interventions to support children with cognitive impairments in low-resource settings. This research aimed to identify and evaluate interventions for youth with neurocognitive deficits in resource-limited...
Source: Children and Youth Services Review - Category: Child Development Authors: Tags: Child Youth Serv Rev Source Type: research
Condition:   Malaria,Falciparum Interventions:   Drug: Artesunate-amodiaquine combination;   Drug: Artemether, Lumefantrine Drug Combination Sponsors:   University of Yaounde 1;   Malaria Research Capacity Development in West and Central Africa Consortium;   Developing Excellence in Leadership, Training and Science Africa Initiative;   Wellcome Trust United Kingdom;   United Kingdom Department for International Development Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Health | Infectious Diseases | Malaria